Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397397
Status:
UNKNOWN
Last Update Posted:
2006-11-09
First Post:
2006-11-08
Brief Title:
Comparative Treatment Study in Patients With Lower Ureteral Stones
Sponsor:
Hillel Yaffe Medical Center
Organization:
Hillel Yaffe Medical Center
Study Overview
Official Title:
Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin10 MG Alfuzosin With Rowatinex and Rowatinex Alone
Status:
UNKNOWN
Status Verified Date:
2006-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We wish to determine the best treatment for expulsion of lower ureteral stones Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones
Detailed Description:
The study will include 60 patients with lower ureteral stones The patients will be divided into three groups The first group will be administered Alfuzosin 10 mg The second group will be administered a combination of Alfuzosin 10 mgand Rowatinex Pinene 31 Camphene 15 Anetol 4 Borneol 10 Cineol 3 Fenchenol 4 Olive Oil 33 The third group will be administered Rowatinex
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None